Oculis Holding AG (OCS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Oculis Holding AG (OCS) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 4:30 PM ESTCompany ParticipantsRiad Sherif - CEO ...

10 Cheap S&P 500 Stocks to Invest in Now

On January 8, Nancy Prial, Co-CEO & Senior Portfolio Manager at Essex Investment Management, appeared on CNBC to suggest that ...
IEEE

Probabilistic Computing with p-Bits: Optimization, Machine Learning and Quantum Simulation

Abstract: The increasing computational demands of the modern AI has been in steady conflict with the slowing down of Moore's Law driven era of electronics. To meet the demands of AI in the new era, ...

Cadrenal Therapeutics Highlights High Incidence of Thrombotic Complications in Heparin-Induced Thrombocytopenia (HIT) at the J.P. Morgan Healthcare Conference and VLX-1005 as a ...

Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today highlighted the ...
Taiwan News

Nature Communications reports promising effect of Idorsia’s lucerastat on kidney function in Fabry disease

In patients with impaired renal function or fast-deteriorating eGFR at baseline, lucerastat was associated with a marked attenuation of kidney function loss, suggesting a potential disease-modifying ...